North Annette
Insider CIK 1341011 · AMBI Senior VP and General Counsel · NONE SVP, General Counsel · TPTX EVP, General Counsel & Secty.
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TPTX Turning Point Therapeutics | A Award deriv | 2022-02-09 | 2022-02-11 | 58,600 | — | $0 | 58,600 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2022-02-09 | 2022-02-11 | 669 | $36.30 | $24.3K | 11,696 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award | 2022-02-09 | 2022-02-11 | 16,283 | — | $0 | 27,979 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise deriv | 2021-08-30 | 2021-08-31 | 10,000 | — | $0 | 144,609 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-08-30 | 2021-08-31 | 10,000 | $80.00 | $800.0K | 12,365 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise | 2021-08-30 | 2021-08-31 | 10,000 | $17.00 | $170.0K | 22,365 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise deriv | 2021-06-15 | 2021-06-16 | 15,000 | — | $0 | 154,609 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-06-15 | 2021-06-16 | 6,634 | $77.82 | $516.3K | 12,365 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-06-15 | 2021-06-16 | 2,700 | $77.37 | $208.9K | 18,999 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise | 2021-06-15 | 2021-06-16 | 15,000 | $17.00 | $255.0K | 27,365 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-06-15 | 2021-06-16 | 5,666 | $75.94 | $430.3K | 21,699 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise deriv | 2021-05-06 | 2021-05-07 | 5,882 | — | $0 | 169,609 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise | 2021-05-06 | 2021-05-07 | 5,882 | $17.00 | $100.0K | 12,365 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise deriv | 2021-03-08 | 2021-03-09 | 20,000 | — | $0 | 175,491 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-03-08 | 2021-03-09 | 4,810 | $109.09 | $524.7K | 21,173 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-03-08 | 2021-03-09 | 4,571 | $110.77 | $506.3K | 7,183 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-03-08 | 2021-03-09 | 9,419 | $109.89 | $1.04M | 11,754 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-03-08 | 2021-03-09 | 700 | $111.69 | $78.2K | 6,483 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-03-08 | 2021-03-09 | 500 | $103.30 | $51.6K | 25,983 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise | 2021-03-08 | 2021-03-09 | 20,000 | $17.00 | $340.0K | 26,483 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award deriv | 2021-02-08 | 2021-02-10 | 29,175 | — | $0 | 29,175 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award | 2021-02-08 | 2021-02-10 | 6,483 | — | $0 | 6,483 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise deriv | 2021-02-02 | 2021-02-02 | 9,016 | — | $0 | 195,491 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise | 2021-02-02 | 2021-02-02 | 9,016 | $17.00 | $153.3K | 9,016 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-02-02 | 2021-02-02 | 604 | $131.89 | $79.7K | 0 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-02-02 | 2021-02-02 | 3,752 | $130.64 | $490.2K | 604 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-02-02 | 2021-02-02 | 2,860 | $129.75 | $371.1K | 4,356 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-02-02 | 2021-02-02 | 500 | $128.74 | $64.4K | 7,216 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-02-02 | 2021-02-02 | 900 | $127.83 | $115.0K | 7,716 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-02-02 | 2021-02-02 | 400 | $126.66 | $50.7K | 8,616 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise deriv | 2021-02-01 | 2021-02-02 | 15,984 | — | $0 | 204,507 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-02-01 | 2021-02-02 | 10,541 | $123.49 | $1.30M | 3,813 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-02-01 | 2021-02-02 | 1,630 | $122.58 | $199.8K | 14,354 | SEC↗ |
| TPTX Turning Point Therapeutics | M Exercise | 2021-02-01 | 2021-02-02 | 15,984 | $17.00 | $271.7K | 15,984 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-02-01 | 2021-02-02 | 3,313 | $124.41 | $412.2K | 500 | SEC↗ |
| TPTX Turning Point Therapeutics | S Sale | 2021-02-01 | 2021-02-02 | 500 | $125.38 | $62.7K | 0 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award deriv | 2020-01-06 | 2020-01-08 | 56,000 | — | $0 | 56,000 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2019-01-22 | 2019-01-24 | 100,000 | — | $0 | 100,000 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2018-01-24 | 2018-01-26 | 70,000 | — | $0 | 70,000 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2017-01-23 | 2017-01-25 | 72,000 | — | $0 | 72,000 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2016-01-29 | 2016-02-02 | 80,000 | — | $0 | 80,000 | SEC↗ |
| NONE Kura Oncology, Inc. | A Award deriv | 2015-04-23 | 2015-04-27 | 81,250 | — | $0 | 81,250 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | D To issuer deriv | 2014-11-10 | 2014-11-12 | 66,000 | $3.19 | $210.5K | 0 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | D To issuer deriv | 2014-11-10 | 2014-11-12 | 63,502 | $15.00 | $952.5K | 0 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | D To issuer deriv | 2014-11-10 | 2014-11-12 | 40,000 | $4.20 | $168.0K | 0 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | A Award deriv | 2014-05-15 | 2014-05-19 | 63,502 | — | $0 | 63,502 | SEC↗ |
| AMBI AMBIT BIOSCIENCES CORP | A Award deriv | 2014-01-08 | 2014-01-10 | 40,000 | — | $0 | 40,000 | SEC↗ |